1. Home
  2. EXEL vs NVMI Comparison

EXEL vs NVMI Comparison

Compare EXEL & NVMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • NVMI
  • Stock Information
  • Founded
  • EXEL 1994
  • NVMI 1993
  • Country
  • EXEL United States
  • NVMI Israel
  • Employees
  • EXEL N/A
  • NVMI N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • NVMI Electronic Components
  • Sector
  • EXEL Health Care
  • NVMI Technology
  • Exchange
  • EXEL Nasdaq
  • NVMI Nasdaq
  • Market Cap
  • EXEL 11.1B
  • NVMI 9.5B
  • IPO Year
  • EXEL 2000
  • NVMI 2000
  • Fundamental
  • Price
  • EXEL $42.52
  • NVMI $289.30
  • Analyst Decision
  • EXEL Buy
  • NVMI Strong Buy
  • Analyst Count
  • EXEL 24
  • NVMI 6
  • Target Price
  • EXEL $44.73
  • NVMI $307.00
  • AVG Volume (30 Days)
  • EXEL 3.3M
  • NVMI 333.3K
  • Earning Date
  • EXEL 11-04-2025
  • NVMI 11-06-2025
  • Dividend Yield
  • EXEL N/A
  • NVMI N/A
  • EPS Growth
  • EXEL 53.55
  • NVMI 44.31
  • EPS
  • EXEL 2.38
  • NVMI 7.71
  • Revenue
  • EXEL $2,288,218,000.00
  • NVMI $852,719,000.00
  • Revenue This Year
  • EXEL $9.14
  • NVMI $32.36
  • Revenue Next Year
  • EXEL $12.51
  • NVMI $7.45
  • P/E Ratio
  • EXEL $17.53
  • NVMI $37.66
  • Revenue Growth
  • EXEL 9.93
  • NVMI 39.37
  • 52 Week Low
  • EXEL $31.90
  • NVMI $154.00
  • 52 Week High
  • EXEL $49.62
  • NVMI $361.32
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 60.26
  • NVMI 37.04
  • Support Level
  • EXEL $41.23
  • NVMI $286.05
  • Resistance Level
  • EXEL $43.72
  • NVMI $321.61
  • Average True Range (ATR)
  • EXEL 1.47
  • NVMI 13.76
  • MACD
  • EXEL 0.34
  • NVMI -6.55
  • Stochastic Oscillator
  • EXEL 83.81
  • NVMI 3.62

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About NVMI Nova Ltd.

Nova Ltd is a semiconductor equipment manufacturer. The company provides metrology solutions for process control used in semiconductor manufacturing. The company offers in-line optical and x-ray stand-alone metrology systems, as well as integrated optical metrology systems. The product range consists of Nova 2040, Nova 3090Next, Nova i500 and i500 Plus, Nova T500, Nova T600, Nova V2600, HelioSense 100, Nova Hybrid Metrology solution, NovaMars. The company generates the majority of its revenue from China. Geographically the company has its business spread across the region of Taiwan, Korea, China, the United States, and Europe.

Share on Social Networks: